anthracis isolate (Ames) (10). To date, however, the immune contribution of human NK cells 78 during B. anthracis infection has not been defined. Further, the role of murine NK cells in 79 experimental models used to study human inhalational anthrax has also not been described. 80
In the current studies we demonstrate that human NK cells are not active against spores, but 81 efficiently reduce CFU of B. anthracis when exposed to both infected autologous monocytes AutoMacs system and cultured with 1400 U/mL GM-CSF as we have previously described (9) . 122 NK cells were negatively selected using an NK cell isolation kit (Miltenyi Biotech) and cultured 123 with media alone or rhIL-15 (15 ng/ml, R&D Systems). In some experiments, monocyte-124 depleted PBMC were used to validate activity of B.anthracis toxins by measuring effects on T 125 cells. T cells were activated using magnetic bead-bound antibodies to human CD3 and CD28 126 were treated with no toxin (NT), the PA component, LT, or edema toxin (ET) as previously 139 described(5). Briefly, NK cells were incubated with PA (2.5 ug/ml), ET (2.5 ug/ml of PA and 140 0.625 ug/ml of EF), LT (1 ug/ml of PA and 0.2 ug/ml of LF), or both ET and LT for one hour prior 141 to addition of media (control) or rIL-15. Similarly PBMC were exposed to toxins for 1 h prior to 142 incubation with human CD3/CD28 bead-conjugated antibodies. 143 Flow cytometry. Purified NK cells or PBMC were harvested at the indicated times and labeled 145 with antibodies (BD Biosciences) specific to human surface markers: CD56-PerCpCy5.5 and 146 CD3-APC-Cy7. Cells were washed and permeabilized using the BD Cytofix/Cytoperm kit (BD 147 Biosciences) followed by labeling with antibodies (BD Biosciences) to intracellular granulysin-148
Alexa-488, Ki67-PE or perforin PE, and IFN-γ-APC. Lastly, cells were washed and resuspended 149 in 400 µl of 2% ultrapure formaldehyde (Polysciences Inc.). A total of 50,000 cells were acquired 150 on a FACS Canto (BD Biosciences) and compensation for spectral overlap was performed 151 using FACS DIVA software (BD Biosciences). Isotype-and fluorochrome-matched non-specific 152 control antibodies were used to determine background fluorescence. Analysis was performed 153 using FCS Express version 3 (De Novo Software) as we have previously described (18 CFU assessment for each treatment to be studied. Following overnight incubation to allow for 160 adherence, supernatants were removed and cells were carefully washed three times with 161 antibiotic free media. MN were then infected at a 1:1 bacterium-to-MN infecting ratio with B. 162
anthracis Ames bacilli, in 50 µl of antibiotic-free cRPMI per well as we have previously 163
described for assessing NK cell activity against mycobacteria (9). Plates were returned to a 164 37°C incubator for 1 h, at which time the supernatants were gently aspirated and each well was 165 washed three times with RPMI 1640 with 10% fetal bovine serum and 50-μg/ml gentamicin to 166 remove extracellular bacilli. Wells were then refilled with 100 µL of antibiotic-free cRPMI alone 167 Richmond, VA) was used to deplete NK cells as previously described (8). The commercial 227 product was reconstituted with 2 mL of sterile water, and a 1:10 dilution was used for injection. anesthetized, followed by euthanasia using CO 2 narcosis. Cervical dislocation was 254 subsequently performed to ensure death as approved by the University of Texas Medical 255
Branch Institutional Animal Care and Use Committee. 500 µl of blood was taken first from 5 256 mice via cardiac puncture and placed in 1.3 ml micro tubes coated with EDTA. After blood was 257 collected, lungs were aseptically removed from 5 mice and placed in 1 ml of PBS in 50-ml 258
Kendall tissue homogenizers (Kendell, Mansfield, MA). Following homogenization of the tissues 259 in the biological safety cabinet in our CDC-approved biological safety level BSL-2 laboratory or 260 animal BSL-3 facility, serial dilutions of blood and lung samples were prepared in PBS, and 261 100 μl of each dilution was plated on 5% sheep blood agar plates (BD Biosciences, Franklin 262 Lakes, NJ). CFU were determined following 48 h growth as previously described (22). 263
Additionally, an aliquot of blood and disrupted tissue was also used to inoculate liquid growth 264 media to determine if bacteria were present. Samples were identified as positive or negative for 265 bacteria following 48 h growth in liquid media and CFU enumeration on blood agar. Fig. 1 and 2 . NK cell reduction of CFU in infected 295 monocytes was substantial, with a 3 log-fold reduction observed at an effector (E) to target (T) 296 ratio of 5:1. A significant (p<0.05) reduction of intracellular bacteria was seen for E:T ratios of 297 5:1, 1:1, and 0. 5:1 and for reduction of extracellular bacteria at E:T ratios of 1:1 and 5:1 (Fig.1  298   C the % of dead and apoptotic cells due to toxin treatment was compared to the spontaneous 308 death/apoptosis in the NT group ( Fig. 2A) . Surprisingly, the toxin treated cells were moderately 309 more viable than the non treated group, and this effect was significant with LT. As shown in Fig.  310 2, the antibacterial activity of NK cells against B. anthracis bacilli (Fig. 2B ) and host cell targets 311 (Fig. 2C) is not impaired due to exposure to anthrax toxins. Though NK cells treated with LT did 312 not mediate a significant reduction of bacilli compared to the NT group (Fig. 2B) , these effects 313 were minimal and were similar to observations observed following treatment with the PA 314 component. In all measurements, the effects of LT + ET were evaluated to determine the 315 potential for additive or synergistic effects and none were noted (data not shown). Thus, viability 316 and CTL function of NK cells are not impaired due to 24 h of exposure to LT, ET, or both. shown to suppress murine T cell activation (5). T cells were activated with magnetic bead-323 conjugated antibodies to CD3 and CD28. As shown with representative donor data in Fig. 3A , T 324 cells were strongly activated to proliferate (Ki67 cell cycle marker) and expressed increased 325 levels of granulysin and IFN-γ, in response to TCR engagement. Exposure to LT reduced T cell 326 expression of both granulysin and IFN-γ upon activation, while proliferation was not affected 327 (Fig. 3A) . ET did not have suppressive effects on the T cell parameters measured here, while 328
treatment with LT + ET produced effects similar to those of LT (data not shown). Consistent with 329 the responses observed in T cells, NK cells proliferated following activation with IL-15 and this 330
response was not impaired by LT (Fig. 3B) 
or ET (data not shown). In contrast to T cells, NK cell 331
expression of granulysin was not significantly impaired by LT though moderate suppression was 332 observed in some donors (Fig. 3B, C) . LT exposure suppressed IFN-γ expression by activated 333 NK cells of several donors, and reached statistical significance with inclusion of 6 individual 334 donors (Fig. 3B, D) . Overall, our results show that similar to T cells, LT suppresses the capacity 335 for NK cells to secrete IFN-γ upon activation. Expression of the antibacterial granulysin protein 336 by activated NK cells, at least in response to IL-15, however, is not impaired by toxin exposure. of B. anthracis Ames spores. In the depleted group, DX5+ cells could not be detected in the 348 spleen of animals as compared to the non-depleted group (Fig. 5A) . Survival data of NK cell 349 depleted and non-depleted Female Swiss Webster mice following intranasal challenge yielded 350 no significant differences between the two groups (Fig.5 B) . The mean time to death in the NK 351 cell depleted group was 2 days vs. the non-depleted control group with a mean time to death of 352 2.5 days post challenge. This experiment was performed a total of 3 times (twice by intranasal organisms while bacteria were not detected in the blood. By 36 h, the lungs and blood from both 369 treatment groups had measurable B. anthracis bacteria. In animals lacking NK cells, the lungs 370 contained a non-significant increase in average bacterial numbers (3.7×10 6 CFU/ml) compared 371 to bacterial numbers (1.8×10 6 CFU/ml) in non-depleted animals. In contrast, a dramatic increase 372 in B. anthracis numbers was observed in the NK cell-depleted animals as compared to the 373 control animals (Fig. 6 B, C) . Thus, the absence of NK cells results in a significant increase in 374 bacteremia by 36 hours. 375
376

DISCUSSION 377
The disease progression during inhalational anthrax is extremely rapid and occurs prior to 378 
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